市場調查報告書
商品編碼
1429022
全球眼科超音波檢測市場評估:依產品、模式、最終用戶、地區、機會、預測(2017-2031)Ophthalmic Ultrasound Market Assessment, By Product, By Modality, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球眼科超音波市場規模將從2023年的6.278億美元增至2031年的11.5858億美元,預計2024-2031年的複合年增長率為7.96%。 由於視力障礙盛行率不斷上升以及對早期準確診斷的需求,全球眼科超音波市場正在迅速擴大。 老化是視力障礙的主要原因。 早期診斷對於管理隨著老化而來的各種視力問題(例如黃斑部病變和老花眼)至關重要。 眼科超音波具有評估眼外傷、評估眼內腫瘤(包括尚未引起視力障礙的小腫瘤)的存在和位置、評估視網膜剝離和評估血管疾病的潛力。
眼科超音波檢查的好處已廣為患者所知,越來越多的人接受這種診斷影像設備。 技術進步、市場進入者推出的產品、醫療保健支出的增加以及可支配收入的增加在眼科超音波檢測市場的成長中發揮著重要作用。 此外,改善獲得眼部保健服務的機會,包括公私夥伴關係和合資企業投資於診斷設備的研發以及為社會經濟地位較低的人提供更有效率和有效的診斷方法。政府的支持和舉措正在進一步推動市場增長。
視力障礙盛行率不斷增加
由於世界各地視力障礙人數不斷增加,對眼科超音波檢查的需求正在迅速增加。 眼科超音波是非侵入性的,能夠提供眼部結構的詳細影像,可用於診斷各種眼部疾病,如白內障、近視、遠視、糖尿病視網膜病變、青光眼、老年黃斑部病變、老花眼等。管理中發揮重要作用。 據世界衛生組織稱,全球有 22 億人患有近距離視力或遠端視力喪失。 據估計,全球每年與視力喪失相關的生產力成本高達 4,110 億美元,給全球衛生系統帶來了沉重的經濟負擔。 低收入和中等收入國家的視力障礙盛行率最高。 透過改善眼鏡的使用以及使用眼科超音波進行準確診斷來進行早期發現和介入是控制視力障礙的關鍵。
眼科超音波技術的進展
超音波技術的技術創新實現了更高的成像能力,為臨床醫生提供了更高的眼部結構可視化精度和細節。 人工智慧與機器學習的融合,進一步提高了診斷準確性,快速且準確地檢測眼部疾病。 超音波診斷設備的小型化提高了便攜性並實現了即時診斷。 2023年6月,AI驅動的眼科超音波和AI療效預測生物標記領域的全球領導者Eyenuk將使用拓普康的視網膜相機NW400,利用AI自動檢測糖尿病視網膜病變,獲得美國FDA批准。 如果及早發現,這種創新產品可以幫助糖尿病患者保留視力。
政府措施
認識到眼病負擔日益加重以及對先進診斷設備的需求,許多政府正在製定支持採用眼科診斷設備的衛生政策和舉措。 資助、研究資助和開發這些診斷設備的補助等計劃鼓勵醫療機構和從業人員將這些設備納入他們的實踐中。 2023 年 5 月,英國國家醫療服務體系 (NHS) 宣布實施新的臨床指南,可以減少英格蘭患者等待眼科護理服務的時間。 該倡議還旨在藉助眼科超音波設備等現代數位診斷設備來改善眼科護理的診斷和治療。 這提高了患者眼部護理的速度和品質。
攜帶式眼科超音波檢查的發展
在產品領域中,便攜式眼科超音波檢查預計在預測期內將快速成長。 該領域的技術進步促進了先進設備的發展,例如輕型便攜式設備,可以為臥床患者和緊急情況提供定點護理服務。 許多主要市場參與者已經認識到該領域不斷增長的需求,並正在推出新的高精度設備。 2023年8月,Alpinion醫療系統有限公司發布了便攜式超音波診斷設備 "X-Cube i9" 。 配備雙電池和探頭連接器。 X-Cube i9 重量輕,高度便攜,只需 1 分鐘即可完成設置,待機模式下運行長達 100 小時,掃描模式下運行超過 1 小時。 該設備提供眼部篩檢、幫助早期檢測和快速分析,並提供床邊護理。
本報告研究和分析了全球眼科超音波檢查市場,提供市場規模和預測、市場動態、主要公司趨勢和前景等。
Global ophthalmic ultrasound market is projected to witness a CAGR of 7.96% during the forecast period 2024-2031, growing from USD 627.8 million in 2023 to USD 1158.58 million in 2031. Due to the rising incidence of vision impairment and the resulting need for early and accurate diagnosis, the global ophthalmic ultrasound market is expanding rapidly. The growing geriatric population is the primary cause of vision impairment. Early diagnosis is crucial for managing various vision problems that arise with age, including macular degeneration and presbyopia. Ophthalmic ultrasound has the potential to provide evaluation of traumatic eye injuries, assessing presence and location of intraocular tumors, including small tumors that have not yet caused visual distortion, evaluation of retinal detachment and evaluation of vascular disease.
The benefits of ophthalmic ultrasounds are becoming more widely known to patients, which has increased acceptance of these diagnostic imaging devices. Technological advancements, product launches by the market players, increased healthcare expenditure, and increasing disposable incomes are playing a major role in the growth of the ophthalmic ultrasound market. Moreover, governmental support and initiatives to improve access to eye care services, such as diagnostic appliances for low socio-economic people and public and private firm's collaborations and joint ventures to invest in research and development of the more efficient and effective diagnostic approaches, further facilitate growth in the global ophthalmic ultrasound market.
Increasing Prevalence of Vision Impairments
There has been a surge in demand for ophthalmic ultrasound due to the rising number of vision impairments worldwide. Ophthalmic ultrasound, with its non-invasive nature and ability to provide detailed images of ocular structures, plays an important role in diagnosing and managing various eye conditions such as cataracts, myopia, hyperopia, diabetic retinopathy, glaucoma, age-related macular degeneration, and presbyopia. According to WHO, 2.2 billion people are suffering from near or distance vision impairment, globally. The annual global cost of productivity associated with vision impairment is estimated to be USD 411 billion, posing a massive financial burden on global healthcare systems. The prevalence of vision impairment is most common in low-and-middle-income-countries. Early detection and early intervention by improving access to eye wear and using ophthalmic ultrasounds for accurate diagnosis are crucial in managing vision impairment.
Technological Advancements in Ophthalmic Ultrasound
Technological innovations in ultrasound technology have enabled high imaging capabilities, providing clinicians with increased accuracy and details in visualizing ocular structures. The integration of artificial intelligence (AI) and machine learning has further facilitated diagnostic accuracy for faster and accurate detection of eye conditions. The miniaturization of ultrasound devices has led to portability, allowing point-of-care diagnostics. In June 2023, Eyenuk, a global leader in AI-based ophthalmic ultrasound and AI Predictive Biomarkers, received U.S. FDA clearance to use the Topcon NW400 retinal camera to automatically detect diabetic retinopathy with the use of AI. This innovative product would help the diabetic patients to save their vision by early detection.
Government Initiatives
Recognizing the growing burden of eye diseases and the need for advanced diagnostic devices, many governments have formulated healthcare policies and initiatives to support the adoption of ophthalmic diagnostic devices. Programs for funding, grants for research, and subsidies for the development of these diagnostic devices have encouraged medical facilities and practitioners to incorporate these devices into their practices. In May 2023, National Health Service (NHS) England announced the implementation of a new clinical guidance, which could reduce waiting times for eye care services for patients in England. The initiative also aims to provide improved eye care diagnosis and treatment with the help of latest digital diagnostic appliances such as ophthalmic ultrasound devices. This will improve the speed and quality of eye care treatment for patients.
Growth in Portable Ophthalmic Ultrasound
Among the product segment, portable ophthalmic ultrasound is expected to grow faster in the forecasted period. Technological advancements in this segment have led to the development of advanced devices, such as light-weight portable devices, that can provide point of care services to the bedridden patients and during emergency locations. Many key market players understand the growing demand of this segment and are launching modern devices with high accuracy and precision. In August 2023, Alpinion Medical Systems Co. Ltd. launched their portable ultrasound device "X-Cube i9". It is equipped with dual batteries and probe connectors. X-Cube i9 is lightweight, has extended portability and sets up in just one minute, providing up to 100 hours of standby mode and more than one hour of scan mode operation. This device will provide ophthalmic screening, be beneficial in early detection and quick analysis, and provide care at the bedside.
North America Holds Largest Share in Ophthalmic Ultrasound Market
North America accounts for a significant share in the global ophthalmic ultrasound market. Robust healthcare infrastructure and advanced healthcare facilities are some of the factors which make North America a global leader in the global healthcare market. Growing awareness of the importance and benefits of screening and early diagnosis in preventing eye diseases drives the global demand for ophthalmic ultrasound. High number of eye surgeries in the region, and availability of many surgeons further leads to increased application of ophthalmic ultrasounds for constant evaluation and screening of eye diseases. There are around 20 million cataract surgeries performed each year, and the United States accounts for 3.7 million surgeries performed each year. In 2020, ophthalmologists performed 800,000 laser refractive procedures and 47,000 corneal transplants in the United States. These surgeries consistently require screening and evaluation, which drives demand in demand in this region. Moreover, key market players like DGH Technology, Inc. and Escalon Medical Corp. play a pivotal role in the availability of advanced medical devices for ophthalmology.
Future Market Scenario
The global ophthalmic ultrasound market is expected to grow in the coming years due to several factors. The global prevalence of vision impairment will increase as the population grows old. This will increase the demand for ophthalmic ultrasound due to its ability to diagnose eye-related disorders with accuracy and precision. Ophthalmic ultrasounds are cost-effective and play a crucial role in providing early intervention. The public increasingly recognizes the importance of early diagnosis and disease prevention for disorders related to the eyes. Technological advancements, government programs, increasing healthcare budgets, and collaborative partnerships between medical device companies, research institutions, and other healthcare providers are some of the factors responsible for driving the market's growth over the forecast period.
Key Players Landscape and Outlook
In the ophthalmic ultrasound market, mergers and acquisitions, partnerships, and distribution agreements are pivotal in driving the global ophthalmic ultrasound market. These alliances empower firms to adapt to each other's strengths, gain access to new markets and technologies, and pool resources for research and development. Distribution agreements enable companies to expand their market presence. These collaborative initiatives promote innovation, expedite product development, and contribute to the growth of the ophthalmic ultrasound market. In October 2022, Halma Plc. announced the acquisition of IZI Medical Products, a leading designer, manufacturer and distributor of diagnostic devices. Through this acquisition the company aims to improve the quality of its diagnostic medical devices, such as ophthalmic ultrasound devices, and enhance its market on a global level.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work